Cold Atmospheric Plasma Device Extension Study

Summary

Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.

Eligibility

Inclusion Criteria:

* All patients from 4-21 years old with at least 1 lesion of vercurra or molluscum.
* Willingness of the participant and their guardian to provide consent when applicable.

Exclusion Criteria:

* Unwillingness to participate in the study
* Received any treatment on the lesion in the past month determined by review of their medical record
* Immunodeficiency determined by review of their medical record.
* Adverse response to prior treatments determined by review of medical record.
* Signs of self-resolution determined by study team members.
* Conditions that lead to excessive scarring determined by study team members.
* Face and genital lesions determined by study team members.

Conditions3

Locations1 site

Browse More Trials